ArticleFrontiers in microbiology2019
Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Article
- Antimicrobial Unusual Small Molecules from MarineInternational journal of molecular sciences · 2025Article
- Mini review: antimicrobial compounds produced by bacteria associated with marine invertebrates.Folia microbiologica · 2025Review
- Evaluation of tirandamycins with selective activity against Enterococci in the silkworm infection model.The Journal of antibiotics · 2025Article
- Article
- Characterization of Antibiotic Actinomycin D Isolated fromInfectious disorders drug targets · 2025Article
- Discovery of two new actinobacteria, Micromonospora palythoicola sp. nov. and Streptomyces poriticola sp. nov., isolated from marine invertebrates.Scientific reports · 2024Article
- Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine SpongeMarine drugs · 2024Article
- A smooth vetch (Frontiers in plant science · 2024Article
- Taxonomic identification and antagonistic activity ofFrontiers in microbiology · 2024Article
- Discovery and biosynthetic assessment of 'Microbial genomics · 2023Article
- Advances in Natural Products from the Marine-Sponge-Associated Microorganisms with Antimicrobial Activity in the Last Decade.Marine drugs · 2023Review
- New insights into the neuroprotective and beta-secretase1 inhibitor profiles of tirandamycin B isolated from a newly found Streptomyces composti sp. nov.Scientific reports · 2023Article
- Identification and genomic analyses of a novel endophytic actinobacteriumFrontiers in microbiology · 2023Article
- Antibacterial Molecules from Marine Microorganisms against Aquatic Pathogens: A Concise Review.Marine drugs · 2022Review
- Biocontrol potential and antifungal mechanism of a novel Streptomyces sichuanensis against Fusarium oxysporum f. sp. cubense tropical race 4 in vitro and in vivo.Applied microbiology and biotechnology · 2022Article
- Genomic and Biocontrol Potential of the Crude Lipopeptide byFrontiers in microbiology · 2022Article
- Natural Products from Actinomycetes Associated with Marine Organisms.Marine drugs · 2021Review
- Bioactive Compounds from Marine Sponges: Fundamentals and Applications.Marine drugs · 2021Review
- A Metataxonomic Approach Reveals Diversified Bacterial Communities in Antarctic Sponges.Marine drugs · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel actinobacterium, strain HNM0039
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.